No Data
No Data
PersonalAIze And RenovaroCube Announce A Strategic Partnership To Develop, Validate, And Commercialize Cube's AI-Driven Platform For Early Detection Of Cancer And Other Diseases
Express News | Renovaro Inc -on Sept 12, Got Deficiency Notice From Nasdaq on Failure to Satisfy Continued Listing Rule or Standard
Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting With Early Cancer Detection
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
Sector Update: Health Care Stocks Softer in Afternoon Trading
Renovaro Offering 20% Stake in Cancer-Diagnostics Subsidiary to Investors; Shares Tumble